Available online 6 April 2015
Review
Taraxacum officinale and related species—An ethnopharmacological review and its potential as a commercial medicinal plant
Abstract
Ethnopharmacological relevance
Dandelion (Taraxacum
spec) is a wild plant that has been used for centuries as a traditional
medicine in the relief and treatment of several diseases. This use is
due to the presence of sesquiterpenes, saponins, phenolic compounds,
flavonoids, and sugars, among others, found in the organs of the plant.
Aim of the study
The aim of this work is to provide a current review of developments and trends in research on the Taraxacum
genus, with a focus on traditional uses and pharmacological properties.
This should shed light on the potential of this plant as an attractive
commercial herbal medicine.
Materials and methods
Documents
were collected, analyzed, and classified for information regarding
medical, agronomic, genetic, and biological aspects of the Taraxacum species. This process was based on a thorough search of documents indexed by scientific search engines.
Results
Two important periods of research on Taraxacum
have been identified: the first, between 1930 and 1950; and the second,
from 1990 to today. During the former, agricultural and genetics
research on this plant were, due to the shortage of natural rubber, the
focus. In contrast, the main drive in Taraxacum research is now the recovery of bioactives and/or applications in medicine.
Pharmacology
is the main area in which these plants have been tested, thanks in part
to its widely known traditional uses; however, there is less than
enthusiastic interest in further human clinical trials. In other areas, Taraxacum
sports an enormous list of compounds of industrial interest; and while
it is true that only a small amount of these compounds is immediately
available in Taraxacum organs and makes it relatively
commercially unattractive, only scarce efforts have been made to improve
yields. Compounding this issue, most studies of its growth and
cultivation have been focused mainly on controlling it as a weed
detrimental to certain industrial crops. To wit, in spite of all the
research carried out, less than 1% of all the species identified so far
(>2500) have been studied (including Taraxacum officinale, Taraxacum coreanum, Taraxacum mongolicum and Taraxacum platycarpum). This is a indication of the little knowledge that we have about this genus so far.
Biotechnology
(involving genetics, agriculture, and biology) is the most powerful
means by which to take advantage of all the medicinal potential of Taraxacum.
Great strides have been made in identifying metabolic pathways for
synthesizing terpenes, one of the most important compound families in
clinical applications. In order to improve yield and performance of the
plant in the field, greenhouse cultivation is another aspect taken into
account, deriving an increase in recovery of bioactives from Taraxacum
organs. Even while considering that only a few species have been
studied, their different biochemical and cultivation profiles indicate
huge potential for qualitative improvements in composition through
genetic engineering, thus directly impacting pharmacological properties.
Conclusions
Taraxacum
is has been traditionally considered a natural remedy, well-inserted
into popular knowledge, but with low commercial applicability. Only once
the recovery of pure and highly reactive compounds can be pursued at (a
qualitatively and quantitatively attractive) economical scale, human
clinical trials would be of interest in order to prove their efficacy
and safety, positioning Taraxacum as an important commercial source of natural drugs.
Keywords
- Ailments;
- Ethnopharmacological;
- Phenolics;
- Sesquiterpenes;
- Taraxacum
Copyright © 2015 Published by Elsevier Ireland Ltd.